Categories: Business

Guru Fundamental Report for NEWR

Below is Validea’s guru fundamental report for NEW RELIC INC (NEWR). Of the 22 guru strategies we follow, NEWR rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit characteristics associated with sustained future growth.

NEW RELIC INC (NEWR) is a mid-cap value stock in the Software & Programming industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.

The following table summarizes whether the stock meets each of this strategy’s tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy’s criteria.

BOOK/MARKET RATIO: PASS
RETURN ON ASSETS: FAIL
CASH FLOW FROM OPERATIONS TO ASSETS: FAIL
CASH FLOW FROM OPERATIONS TO ASSETS VS. RETURN ON ASSETS: PASS
RETURN ON ASSETS VARIANCE: PASS
SALES VARIANCE: PASS
ADVERTISING TO ASSETS: PASS
CAPITAL EXPENDITURES TO ASSETS: PASS
RESEARCH AND DEVELOPMENT TO ASSETS: PASS

Detailed Analysis of NEW RELIC INC

NEWR Guru Analysis

NEWR Fundamental Analysis

More Information on Partha Mohanram

Partha Mohanram Portfolio

About Partha Mohanram: Sometimes the best investing strategies don’t come from the world of investing. Sometimes research that changes the investing world can come from the halls of academia. Partha Mohanram is a great example of this. While academic research has shown that value investing works over time, it has found the opposite for growth investing. Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. His research paper “Separating Winners from Losers among Low Book-to-Market Stocks using Financial Statement Analysis” looked at the criteria that can be used to separate growth stocks that continue their upward trajectory from those that don’t. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School.

Additional Research Links

Factor-Based Stock Portfolios

Factor-Based ETF Portfolios

Harry Browne Permanent Portfolio

Ray Dalio All Weather Portfolio

About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source link

nasdaqpicks.com

Share
Published by
nasdaqpicks.com

Recent Posts

Churchill in Moscow review — Roger Allam stars in a timely reflection on realpolitik

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…

14 minutes ago

Choke Enough album review — hyperpop gets the grown-up treatment

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…

30 minutes ago

Why Argentina is back in love with the peso — for now

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…

46 minutes ago

Illinois politician Mike Madigan found guilty of bribery and wire fraud

Unlock the White House Watch newsletter for freeYour guide to what the 2024 US election…

1 hour ago

Semiconductor equipment manufacturing firm Lam Research to invest ₹10,000 crore in Karnataka

Global semiconductor equipment manufacturing firm Lam Research has committed an investment of over ₹10,000 crore…

1 hour ago

Kauvery Hospitals’ investment arm invests in start-up Lifesigns

Healthcare Capital, the investment arm of the Kauvery Hospital Group, has invested an undisclosed amount…

1 hour ago